Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 2.230
+0.060 (2.76%)
Jun 1, 2026, 4:08 PM HKT
Luye Pharma Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,908 | 10,945 | 8,163 | 14,031 | 12,992 | 12,607 | |
Market Cap Growth | 19.00% | 34.08% | -41.82% | 8.00% | 3.05% | 7.49% |
Enterprise Value | 14,590 | 16,301 | 12,502 | 17,078 | 18,013 | 16,610 |
Last Close Price | 2.23 | 2.74 | 2.17 | 3.73 | 3.66 | 3.56 |
PE Ratio | 12.62 | 15.90 | 16.26 | 23.91 | 19.00 | - |
Forward PE | 10.98 | 12.80 | 8.49 | 17.57 | 17.45 | 8.01 |
PS Ratio | 1.27 | 1.56 | 1.26 | 2.07 | 1.92 | 1.98 |
PB Ratio | 0.44 | 0.54 | 0.49 | 0.94 | 1.04 | 1.13 |
P/TBV Ratio | 0.84 | 1.03 | 1.00 | 1.91 | 2.43 | 3.00 |
P/FCF Ratio | 6.29 | 7.73 | - | 13.23 | 11.51 | - |
P/OCF Ratio | 4.49 | 5.52 | 45.72 | 7.98 | 6.95 | 56.32 |
PEG Ratio | - | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 |
EV/Sales Ratio | 2.08 | 2.32 | 1.94 | 2.52 | 2.66 | 2.60 |
EV/EBITDA Ratio | 6.49 | 7.27 | 6.21 | 9.98 | 11.18 | 14.92 |
EV/EBIT Ratio | 11.05 | 12.03 | 10.34 | 17.47 | 20.19 | 37.24 |
EV/FCF Ratio | 10.31 | 11.52 | - | 16.10 | 15.96 | - |
Debt / Equity Ratio | 0.56 | 0.56 | 0.66 | 0.62 | 0.83 | 1.04 |
Debt / EBITDA Ratio | 5.02 | 5.02 | 5.38 | 5.33 | 6.27 | 10.09 |
Debt / FCF Ratio | 8.11 | 8.11 | - | 8.75 | 9.12 | - |
Net Debt / Equity Ratio | 0.15 | 0.15 | 0.24 | 0.17 | 0.32 | 0.44 |
Net Debt / EBITDA Ratio | 1.40 | 1.40 | 2.02 | 1.49 | 2.50 | 4.39 |
Net Debt / FCF Ratio | 2.22 | 2.22 | -8.96 | 2.41 | 3.57 | -10.65 |
Asset Turnover | 0.20 | 0.20 | 0.22 | 0.25 | 0.26 | 0.24 |
Inventory Turnover | 2.30 | 2.30 | 2.32 | 2.42 | 2.42 | 2.66 |
Quick Ratio | 1.26 | 1.26 | 1.01 | 1.08 | 0.83 | 1.08 |
Current Ratio | 1.53 | 1.53 | 1.24 | 1.32 | 1.14 | 1.42 |
Return on Equity (ROE) | 4.14% | 4.14% | 4.41% | 4.39% | 5.79% | -1.68% |
Return on Assets (ROA) | 2.44% | 2.44% | 2.58% | 2.23% | 2.11% | 1.05% |
Return on Invested Capital (ROIC) | 4.29% | 4.46% | 4.93% | 4.49% | 4.96% | 2.82% |
Return on Capital Employed (ROCE) | 5.30% | 5.30% | 6.00% | 5.10% | 5.30% | 2.40% |
Earnings Yield | 7.73% | 6.29% | 6.15% | 4.18% | 5.26% | -1.31% |
FCF Yield | 15.89% | 12.93% | -5.56% | 7.56% | 8.69% | -3.64% |
Buyback Yield / Dilution | -3.57% | -3.57% | -0.89% | -7.11% | -1.03% | -7.87% |
Total Shareholder Return | -3.57% | -3.57% | -0.89% | -7.11% | -1.03% | -7.87% |